Research Article
Diagnostic and Prognostic Role of Serum Omentin and NGAL Levels in Egyptian Breast Cancer Patients
Table 3
Relation between serum level of NGAL (ng/ml) and clinicopathological characteristic of the 120 studied cases.
| | | NGAL (ng/ml) () | value |
| | Age | <40 | | 0.006 | | ≥40 | |
| | Tumor size | T0-T1 | | 0.005 | | T2 | | | T3 | | | T4 | |
| | Lymph node | N0 | | 0.03 | | N1 | | | N2 | | | N3 | | | Unknown (X) | |
| | Metastasis | Yes | | 0.007 | | No | |
| | Tumor grade | G1 | | 0.23 | | G2 | | | G3 | | | Unknown (X) | |
| | Estrogen receptor (ER) | Positive | | 0.58 | | Negative | | | Unknown (X) | |
| | Progesterone receptor (PR) | Positive | | 0.46 | | Negative | | | Unknown (X) | |
| | HER2neu | Positive | | 0.83 | | Negative | | | Unknown (X) | |
|
|
